| Year |
Citation |
Score |
| 2007 |
Paul J, Strickland S, Melchor JP. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. The Journal of Experimental Medicine. 204: 1999-2008. PMID 17664291 DOI: 10.1084/Jem.20070304 |
0.327 |
|
| 2003 |
Melchor JP, Pawlak R, Strickland S. The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 8867-71. PMID 14523088 |
0.584 |
|
| 2003 |
Melchor JP, Pawlak R, Chen Z, Strickland S. The possible role of tissue-type plasminogen activator (tPA) and tPA blockers in the pathogenesis and treatment of Alzheimer's disease. Journal of Molecular Neuroscience : Mn. 20: 287-9. PMID 14501010 DOI: 10.1385/Jmn:20:3:287 |
0.525 |
|
| 2003 |
Melchor JP, Pawlak R, Strickland S. The Tissue Plasminogen Activator-Plasminogen Proteolytic Cascade Accelerates Amyloid-β (Aβ) Degradation and Inhibits Aβ-Induced Neurodegeneration The Journal of Neuroscience. 23: 8867-8871. DOI: 10.1523/Jneurosci.23-26-08867.2003 |
0.417 |
|
| 2002 |
Van Nostrand WE, Melchor JP, Romanov G, Zeigler K, Davis J. Pathogenic effects of cerebral amyloid angiopathy mutations in the amyloid beta-protein precursor. Annals of the New York Academy of Sciences. 977: 258-65. PMID 12480759 DOI: 10.1111/J.1749-6632.2002.Tb04824.X |
0.746 |
|
| 2002 |
Van Nostrand WE, Melchor JP, Keane DM, Saporito-Irwin SM, Romanov G, Davis J, Xu F. Localization of a fibrillar amyloid beta-protein binding domain on its precursor. The Journal of Biological Chemistry. 277: 36392-8. PMID 12107175 DOI: 10.1074/jbc.M204676200 |
0.724 |
|
| 2001 |
Van Nostrand WE, Melchor JP. Disruption of pathologic amyloid beta-protein fibril assembly on the surface of cultured human cerebrovascular smooth muscle cells. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 8: 20-7. PMID 11676286 |
0.744 |
|
| 2001 |
Van Nostrand WE, Melchor JP, Cho HS, Greenberg SM, Rebeck GW. Pathogenic Effects of D23N Iowa Mutant Amyloid β-Protein Journal of Biological Chemistry. 276: 32860-32866. PMID 11441013 DOI: 10.1074/Jbc.M104135200 |
0.723 |
|
| 2000 |
Wagner MR, Keane DM, Melchor JP, Auspaker KR, Van Nostrand WE. Fibrillar amyloid beta-protein binds protease nexin-2/amyloid beta-protein precursor: stimulation of its inhibition of coagulation factor XIa. Biochemistry. 39: 7420-7. PMID 10858290 DOI: 10.1021/bi0002840 |
0.727 |
|
| 2000 |
Van Nostrand WE, Melchor J, Wagner M, Davis J. Cerebrovascular smooth muscle cell surface fibrillar aβ Annals of the New York Academy of Sciences. 903: 89-96. PMID 10818493 DOI: 10.1111/J.1749-6632.2000.Tb06354.X |
0.683 |
|
| 2000 |
Melchor JP, McVoy L, Van Nostrand WE. Charge alterations of E22 enhance the pathogenic properties of the amyloid beta-protein. Journal of Neurochemistry. 74: 2209-12. PMID 10800967 DOI: 10.1046/J.1471-4159.2000.0742209.X |
0.747 |
|
| 2000 |
Melchor JP, Van Nostrand WE. Fibrillar amyloid beta-protein mediates the pathologic accumulation of its secreted precursor in human cerebrovascular smooth muscle cells. The Journal of Biological Chemistry. 275: 9782-91. PMID 10734132 DOI: 10.1074/Jbc.275.13.9782 |
0.752 |
|
| 2000 |
Melchor JP, McVoy L. Charge alterations of E22 enhance the pathogenic properties of the amyloid-β protein Neurobiology of Aging. 21: 11. DOI: 10.1016/S0197-4580(00)82727-X |
0.366 |
|
| 1998 |
Van Nostrand WE, Melchor JP, Ruffini L. Pathologic amyloid beta-protein cell surface fibril assembly on cultured human cerebrovascular smooth muscle cells. Journal of Neurochemistry. 70: 216-23. PMID 9422365 DOI: 10.1046/J.1471-4159.1998.70010216.X |
0.647 |
|
| Show low-probability matches. |